Johnson & Johnson (JNJ) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4781601046

Johnson & Johnson, along with its subsidiaries, specializes in researching, developing, manufacturing, and selling a wide range of healthcare products globally. The company's Innovative Medicine segment focuses on products for various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, cardiovascular, metabolism, and pulmonary hypertension. These products are distributed through various channels such as retailers, wholesalers, distributors, hospitals, and healthcare professionals primarily for prescription use.

In addition to healthcare products, Johnson & Johnson's MedTech segment offers Interventional Solutions for heart rhythm disorders, heart recovery technologies for severe coronary artery disease, neurovascular care for stroke treatment, orthopedic solutions for hips, knees, trauma, spine, and sports-related injuries, surgery technologies including breast aesthetics and ear, nose, and throat procedures, as well as contact lenses and intraocular lenses for cataract surgery under various brands. The company distributes these products to wholesalers, hospitals, retailers, physicians, nurses, eye care professionals, and clinics.

Established in 1886 and headquartered in New Brunswick, New Jersey, Johnson & Johnson continues to be a leading force in the healthcare industry with a diverse portfolio of innovative products dedicated to improving and enhancing global health. For more information, visit their website at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Johnson & Johnson (JNJ) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Johnson & Johnson (JNJ) - Stock Price & Dividends

JNJ Stock Overview

Market Cap in USD 358,551m
Sector Healthcare
Industry Drug Manufacturers - General
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1944-09-24

JNJ Stock Ratings

Growth 5y 3.06
Fundamental 8.06
Dividend 6.80
Rel. Performance vs Sector -1.42
Analysts 3.68/5
Fair Price Momentum 125.97 USD
Fair Price DCF 211.78 USD

JNJ Dividends

Yield 12m 3.27%
Yield on Cost 5y 3.93%
Dividends CAGR 5y 4.62%
Payout Consistency 88.6%

JNJ Growth Ratios

Growth 12m -8.86%
Growth Correlation 12m -15%
Growth Correlation 3m -46%
CAGR 5y 3.75%
Sharpe Ratio 12m -0.94
Alpha vs SP500 12m -24.58
Beta vs SP500 5y weekly 0.59
ValueRay RSI 8.41
Volatility GJR Garch 1y 17.82%
Price / SMA 50 -6.71%
Price / SMA 200 -7.57%
Current Volume 9887.7k
Average Volume 20d 7468.2k

External Links for JNJ Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of JNJ stocks?
As of April 19, 2024, the stock is trading at USD 145.74 with a total of 9,887,704 shares traded.
Over the past week, the price has changed by -2.05%, over one month by -7.03%, over three months by -9.60% and over the past year by -7.40%.
What is the forecast for JNJ stock price target?
According to ValueRays Forecast Model, JNJ Johnson & Johnson will be worth about 138.6 in April 2025. The stock is currently trading at 145.74. This means that the stock has a potential downside of -4.93%.
Issuer Forecast Upside
Wallstreet Target Price 162.2 11.3%
Analysts Target Price 168.5 15.6%
ValueRay Target Price 138.6 -4.93%

Johnson & Johnson: Navigating Through History to Modern Success

History at a Glance

Johnson & Johnson (J&J), founded in 1886 by three Johnson brothers, Robert, James, and Edward, began its journey with the aim of producing sterile surgical supplies. This innovation marked the start of a company that would grow to become a cornerstone in the healthcare industry, paving the way with its commitment to improving health for people worldwide.

Core Businesses

J&J has strategically branched out into three main sectors over the years: Pharmaceuticals, Medical Devices, and Consumer Health Products. The Pharmaceuticals division focuses on researching and developing medications for various diseases. The Medical Devices sector offers a wide range of health care products used by professionals. Lastly, the Consumer Health Products division brings everyday health and personal care products to consumers worldwide.

Side Businesses and Diversification

Beyond its primary operations, J&J has also ventured into areas such as digital health solutions and acquisitions that complement its core businesses. This diversification not only expands J&J’s portfolio but also strengthens its position in the healthcare market by meeting a broader range of consumer and medical needs.

Current Market Status

As of today, Johnson & Johnson stands as a giant in the healthcare field, with a strong presence on the New York Stock Exchange (NYSE: JNJ). Despite the complexities and competitive nature of the healthcare industry, J&J has demonstrated resilience and growth. Its commitment to innovation, research, and development continues to drive the company forward, ensuring its place as a leader in providing healthcare solutions.